Article info
Short report
Calprotectin instability may lead to undertreatment in children with IBD
- Correspondence to Dr Patrick Ferry van Rheenen, Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Groningen, University Medical Center Groningen, Groningen 9700 RB, The Netherlands; p.f.van.rheenen{at}umcg.nl
Citation
Calprotectin instability may lead to undertreatment in children with IBD
Publication history
- Received November 21, 2018
- Revised December 10, 2018
- Accepted December 19, 2018
- First published January 17, 2019.
Online issue publication
September 18, 2020
Article Versions
- Previous version (17 January 2019).
- Previous version (10 June 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.